Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11.

Ishikawa Y, Kawashima N, Atsuta Y, Sugiura I, Sawa M, Dobashi N, Yokoyama H, Doki N, Tomita A, Kiguchi T, Koh S, Kanamori H, Iriyama N, Kohno A, Moriuchi Y, Asada N, Hirano D, Togitani K, Sakura T, Hagihara M, Tomikawa T, Yokoyama Y, Asou N, Ohtake S, Matsumura I, Miyazaki Y, Naoe T, Kiyoi H.

Blood Adv. 2020 Jan 14;4(1):66-75. doi: 10.1182/bloodadvances.2019000709.

2.

Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory marginal zone lymphoma.

Yamasaki S, Chihara D, Yoshida I, Kohda K, Sawa M, Ago H, Togitani K, Ohno Y, Tanaka J, Fukuda T, Atsuta Y, Suzumiya J, Suzuki R.

Ann Hematol. 2019 Jun;98(6):1521-1523. doi: 10.1007/s00277-018-3587-z. Epub 2018 Dec 17. No abstract available.

PMID:
30560447
3.

TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.

Takayama Y, Kubota T, Ogino Y, Ohnishi H, Togitani K, Yokoyama A.

Intern Med. 2018 May 1;57(9):1291-1296. doi: 10.2169/internalmedicine.9484-17. Epub 2017 Dec 27.

4.

Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study.

Takahashi N, Tauchi T, Kitamura K, Miyamura K, Saburi Y, Hatta Y, Miyata Y, Kobayashi S, Usuki K, Matsumura I, Minami Y, Usui N, Fukuda T, Takada S, Ishikawa M, Fujimaki K, Gomyo H, Sasaki O, Ohishi K, Miyake T, Imai K, Suzushima H, Mitsui H, Togitani K, Kiguchi T, Atsuta Y, Ohtake S, Ohnishi K, Kobayashi Y, Kiyoi H, Miyazaki Y, Naoe T; Japan Adult Leukemia Study Group.

Int J Hematol. 2018 Feb;107(2):185-193. doi: 10.1007/s12185-017-2334-x. Epub 2017 Sep 19.

PMID:
28929332
5.

Spontaneous remission of aleukemic cutaneous myeloid sarcoma followed by crisis of acute monoblastic leukemia.

Takahashi A, Nakajima K, Togitani K, Aoki N, Miyoshi K, Sano S.

J Dermatol. 2016 Apr;43(4):452-3. doi: 10.1111/1346-8138.13202. Epub 2015 Dec 12. No abstract available.

PMID:
26661142
6.

Young adult onset systemic Epstein-Barr virus-positive T-cell lymphoproliferative disorders of childhood.

Sakai M, Togitani K, Tsukuda T, Arakawa Y, Ikezoe T, Hiroi M, Yokoyama A.

Rinsho Ketsueki. 2015 May;56(5):501-5. doi: 10.11406/rinketsu.56.501. Japanese.

PMID:
26062673
7.

Successful re-administration of lenalidomide after lenalidomide-induced pulmonary alveolar hemorrhage in a patient with refractory myeloma.

Sakai M, Kubota T, Takaoka M, Tsukuda T, Arakawa Y, Anabuki K, Ikezoe T, Togitani K, Yokoyama A.

Ann Hematol. 2015 May;94(5):891-2. doi: 10.1007/s00277-014-2260-4. Epub 2014 Nov 20. No abstract available.

PMID:
25407112
8.

Clinicopathological characteristics and therapeutic outcomes of synchronous gastric adenocarcinoma and gastric lymphoma.

Namikawa T, Munekage E, Fukudome I, Maeda H, Kitagawa H, Togitani K, Takasaki M, Yokoyama A, Kobayashi M, Hanazaki K.

Anticancer Res. 2014 Sep;34(9):5067-74. Review.

PMID:
25202092
9.

[Successful eculizumab treatment for multiple coronary thrombosis complicated in paroxysmal nocturnal hemoglobinuria].

Taniguchi A, Ikezoe T, Takeuchi A, Togitani K, Yoshimoto M, Tanioka K, Kitaoka H, Yokoyama A.

Rinsho Ketsueki. 2014 Aug;55(8):965-9. Japanese.

PMID:
25186487
10.

Effect of recombinant human soluble thrombomodulin on clinical outcomes of patients with coagulopathy after hematopoietic stem cell transplantation.

Ikezoe T, Takeuchi A, Chi S, Takaoka M, Anabuki K, Kim T, Sakai M, Taniguchi A, Togitani K, Yokoyama A.

Eur J Haematol. 2013 Nov;91(5):442-7. doi: 10.1111/ejh.12188. Epub 2013 Oct 1.

PMID:
23952647
11.

Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.

Ikezoe T, Takeuchi A, Isaka M, Arakawa Y, Iwabu N, Kin T, Anabuki K, Sakai M, Taniguchi A, Togitani K, Yokoyama A.

Leuk Res. 2012 Nov;36(11):1398-402. doi: 10.1016/j.leukres.2012.08.012. Epub 2012 Aug 21.

PMID:
22917769
12.

Recombinant human soluble thrombomodulin counteracts capillary leakage associated with engraftment syndrome.

Ikezoe T, Takeuchi A, Taniguchi A, Togitani K, Yokoyama A.

Bone Marrow Transplant. 2011 Apr;46(4):616-8. doi: 10.1038/bmt.2010.158. Epub 2010 Jul 5. No abstract available.

PMID:
20603623
13.

Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib.

Ikezoe T, Togitani K, Tasaka T, Nishioka C, Yokoyama A.

Leuk Res. 2010 Aug;34(8):e200-1. doi: 10.1016/j.leukres.2010.02.024. Epub 2010 Mar 29. No abstract available.

PMID:
20303172
14.

Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin.

Sakai M, Ikezoe T, Bandobashi K, Togitani K, Yokoyama A.

Bone Marrow Transplant. 2010 Apr;45(4):803-5. doi: 10.1038/bmt.2009.242. Epub 2009 Sep 21. No abstract available.

PMID:
19767779
15.

Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.

Ikezoe T, Togitani K, Komatsu N, Isaka M, Yokoyama A.

Bone Marrow Transplant. 2010 Apr;45(4):783-5. doi: 10.1038/bmt.2009.217. Epub 2009 Aug 31. No abstract available.

PMID:
19718058
16.

A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies.

Ikezoe T, Yang J, Nishioka C, Takezaki Y, Tasaka T, Togitani K, Koeffler HP, Yokoyama A.

Leukemia. 2009 Sep;23(9):1564-76. doi: 10.1038/leu.2009.94. Epub 2009 May 7.

PMID:
19421227
17.

The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma: a propensity score matching analysis.

Nishimori H, Matsuo K, Maeda Y, Nawa Y, Sunami K, Togitani K, Takimoto H, Hiramatsu Y, Kiguchi T, Yano T, Yamane H, Tabayashi T, Takeuchi M, Makita M, Sezaki N, Yamasuji Y, Sugiyama H, Tabuchi T, Kataoka I, Fujii N, Ishimaru F, Shinagawa K, Ikeda K, Hara M, Yoshino T, Tanimoto M; West-Japan Hematology and Oncology Group (West-JHOG).

Int J Hematol. 2009 Apr;89(3):326-331. doi: 10.1007/s12185-009-0259-8. Epub 2009 Mar 27.

PMID:
19326060
18.

Ki11502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo.

Nishioka C, Ikezoe T, Yang J, Miwa A, Tasaka T, Kuwayama Y, Togitani K, Koeffler HP, Yokoyama A.

Blood. 2008 May 15;111(10):5086-92. doi: 10.1182/blood-2007-06-098079. Epub 2008 Feb 28.

20.

Blockade of MEK/ERK signaling enhances sunitinib-induced growth inhibition and apoptosis of leukemia cells possessing activating mutations of the FLT3 gene.

Nishioka C, Ikezoe T, Yang J, Takeshita A, Taniguchi A, Komatsu N, Togitani K, Koeffler HP, Yokoyama A.

Leuk Res. 2008 Jun;32(6):865-72. Epub 2007 Nov 5.

PMID:
17983653
21.

Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB.

Nishioka C, Ikezoe T, Yang J, Komatsu N, Bandobashi K, Taniguchi A, Kuwayama Y, Togitani K, Koeffler HP, Taguchi H.

Leuk Res. 2008 Feb;32(2):287-96. Epub 2007 Jul 20.

PMID:
17644177
22.

A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia.

Ikezoe T, Yang J, Nishioka C, Tasaka T, Taniguchi A, Kuwayama Y, Komatsu N, Bandobashi K, Togitani K, Koeffler HP, Taguchi H.

Mol Cancer Ther. 2007 Jun;6(6):1851-7. Epub 2007 May 31.

23.

AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo.

Yang J, Ikezoe T, Nishioka C, Tasaka T, Taniguchi A, Kuwayama Y, Komatsu N, Bandobashi K, Togitani K, Koeffler HP, Taguchi H, Yokoyama A.

Blood. 2007 Sep 15;110(6):2034-40. Epub 2007 May 10.

PMID:
17495131
24.

Ethmoidal sinusitis caused by Exserohilum rostratum in a patient with malignant lymphoma after non-myeloablative allogeneic peripheral blood stem cell transplantation.

Togitani K, Kobayashi M, Sakai M, Uemura Y, Taguchi H, Morita T, Sugihara S, Sano A, Nishimura K.

Transpl Infect Dis. 2007 Jun;9(2):137-41.

PMID:
17462000
25.

Bilateral endobronchial involvement in mantle cell lymphoma.

Miyoshi I, Togitani K, Kuwayama Y, Daibata M, Matsumoto M, Taguchi H.

Intern Med. 2007;46(7):429-30. Epub 2007 Apr 2. No abstract available.

26.

ZD6474 induces growth arrest and apoptosis of human leukemia cells, which is enhanced by concomitant use of a novel MEK inhibitor, AZD6244.

Nishioka C, Ikezoe T, Takeshita A, Yang J, Tasaka T, Yang Y, Kuwayama Y, Komatsu N, Togitani K, Koeffler HP, Taguchi H.

Leukemia. 2007 Jun;21(6):1308-10. Epub 2007 Mar 15. No abstract available.

PMID:
17361222
27.
28.

Absence of Chlamydia psittaci in ocular adnexal lymphoma from Japanese patients.

Daibata M, Nemoto Y, Togitani K, Fukushima A, Ueno H, Ouchi K, Fukushi H, Imai S, Taguchi H.

Br J Haematol. 2006 Mar;132(5):651-2. No abstract available.

PMID:
16445841
29.

Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways.

Ikezoe T, Yang Y, Bandobashi K, Saito T, Takemoto S, Machida H, Togitani K, Koeffler HP, Taguchi H.

Mol Cancer Ther. 2005 Apr;4(4):578-86.

30.

Molecular polymerase chain reaction diagnosis of pulmonary mucormycosis caused by Cunninghamella bertholletiae.

Kobayashi M, Togitani K, Machida H, Uemura Y, Ohtsuki Y, Taguchi H.

Respirology. 2004 Aug;9(3):397-401.

PMID:
15363015
31.

A nationwide survey of deep fungal infections and fungal prophylaxis after hematopoietic stem cell transplantation in Japan.

Imataki O, Kami M, Kim SW, Gotoh M, Komaba S, Kasai M, Hashino S, Naito K, Masuda M, Anan K, Teshima H, Togitani K, Inoue T, Nishimura M, Adachi Y, Fukuhara T, Yamashita T, Uike N, Kobayashi Y, Hamaguchi M, Higuchi M, Kawakami K, Takaue Y.

Bone Marrow Transplant. 2004 Jun;33(12):1173-9.

PMID:
15094754
32.

Granular lymphocytic leukemia derived from gamma delta T-cell expressing cytotoxic molecules.

Saito T, Togitani K, Murakami J, Watanabe T, Tanosaki R, Kobayashi Y, Matsuno Y, Tobinai K.

Leuk Res. 2001 Mar;25(3):259-61.

PMID:
11226523
33.

Successful allogeneic bone marrow transplantation in a case of adult precursor B-lymphoblastic lymphoma.

Murayama T, Takenaka T, Matsuno Y, Takeyama K, Togitani K, Yokozawa T, Kobayashi Y, Tobinai K.

Int J Hematol. 2000 Dec;72(4):504-6.

PMID:
11197221
34.

Cardiac conduction abnormalities in patients with breast cancer undergoing high-dose chemotherapy and stem cell transplantation.

Ando M, Yokozawa T, Sawada J, Takaue Y, Togitani K, Kawahigashi N, Narabayashi M, Takeyama K, Tanosaki R, Mineishi S, Kobayashi Y, Watanabe T, Adachi I, Tobinai K.

Bone Marrow Transplant. 2000 Jan;25(2):185-9.

35.

[Central nervous system relapse with multiple brain masses in an acute promyelocytic leukemia patient treated with all-trans retinoic acid].

Maeda A, Kobayashi Y, Saito T, Togitani K, Kawahigashi N, Tanosaki R, Takaue Y, Takenaka T, Iwata N, Tobinai K.

Rinsho Ketsueki. 1999 Oct;40(10):1081-6. Japanese.

PMID:
10565225
36.

Therapy-related leukemia and myelodysplastic syndrome in breast cancer patients treated with cyclophosphamide or anthracyclines.

Ando M, Narabayashi M, Watanabe T, Kamiya Y, Togitani K, Tanosaki R, Takenaka T, Tobinai K, Adachi I.

Jpn J Clin Oncol. 1999 Jan;29(1):28-32.

PMID:
10073148
37.

[Rapid tapering of cyclosporine for cytogenetic relapse shortly after bone marrow transplantation in a patient with chronic myeloid leukemia].

Kobayashi Y, Nakata M, Sato N, Kamiya Y, Maeda A, Togitani K, Kawahigashi N, Murayama T, Yokozawa T, Takeyama K, Narabayashi M, Takenaka T, Tobinai K.

Rinsho Ketsueki. 1998 Jun;39(6):466-9. Japanese.

PMID:
9695678
38.

Thrombotic microangiopathy of hyperacute onset after autologous peripheral blood stem cell transplantation in malignant lymphoma.

Togitani K, Takeyama K, Yokozawa T, Andoh M, Narabayashi M, Kobayashi Y, Takenaka T, Tobinai K.

Bone Marrow Transplant. 1998 Jun;21(12):1263-6.

39.

Refractory anemia with an excess of blasts developed into overt leukemia with leukothrombocytosis.

Takahashi I, Togitani K, Yokoyama M, Aita T, Makihata K, Sunami K, Shiromoto M, Nakamura T, Kawada I, Nishimura M, et al.

Intern Med. 1995 Jan;34(1):28-31.

Supplemental Content

Loading ...
Support Center